🇺🇸 FDA
Patent

US 6110695

Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1

expired A61KA61K38/00

Quick answer

US patent 6110695 (Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1) held by The Regents of the University of California expires Mon Aug 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 29 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K38/00